Entry Detail



General Information

Database ID:exR0091697
RNA Name:hsa-miR-15a-5p
RNA Type:miRNA
Chromosome:chr13
Starnd:-
Coordinate:
Start Site(bp):50049167End Site(bp):50049188
External Links:hsa-miR-15a-5p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
SPRYD3
chr12
53064316
53079404
-
FAM89A
chr1
231018958
231040254
-
ZNF664
chr12
123971845
124015439
+
ABCF3
chr3
184186023
184194012
+
LITAF
chr16
11547722
11636381
-
GPR107
chr9
130053426
130140169
+
CTTNBP2
chr7
117710651
117874139
-
MED11
chr17
4731428
4733607
+
ABHD2
chr15
89087459
89202355
+
UNC119B
chr12
120710458
120723640
+
AADAT
chr4
170060222
170091699
-
KLHDC3
chr6
43014103
43021298
+
JARID2
chr6
15246069
15522042
+
ITPR1
chr3
4493345
4847840
+
MAPK1IP1L
chr14
55051647
55070194
+
ANKRD17
chr4
73073376
73258798
-
SRPK1
chr6
35832966
35921342
-
STEAP3
chr2
119223831
119265652
+
AMER1
chrX
64185117
64205708
-
ASB1
chr2
238426742
238452250
+
ARL1
chr12
101393116
101407772
-
MRPS2
chr9
135499984
135504673
+
SCAMP4
chr19
1905372
1926013
+
ATXN7L3
chr17
44191805
44200113
-
ZBTB34
chr9
126860665
126885878
+
PLPP6
chr9
4662294
4665258
+
ERG28
chr14
75649791
75660876
-
TSPYL2
chrX
53082367
53088540
+
ADGRL1
chr19
14147743
14206187
-
TBL1X
chrX
9463295
9741037
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000540
chr14
55799534
55821940
+
hsa_circ_0001005
chr2
53921020
53978078
-
hsa_circ_0001723
chr7
91924202
91948826
+
hsa_circ_0000458
chr12
124071293
124074996
+
hsa_circ_0001699
chr7
40027197
40041630
+
hsa_circ_0001387
chr4
1902352
1936989
+
hsa_circ_0001168
chr20
47691321
47707559
+
hsa_circ_0000552
chr14
71880664
71948928
+
hsa_circ_0000038
chr1
28800065
28802803
+
hsa_circ_0000652
chr15
90984737
90986710
+
hsa_circ_0001472
chr5
36953719
36976504
+
hsa_circ_0001263
chr3
5215701
5216099
+
hsa_circ_0000799
chr17
65941524
65972074
+
hsa_circ_0001164
chr20
45891031
45923523
-
hsa_circ_0000032
chr1
25666964
25669564
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
XIST
chrX
73820649
73852723
-
NEAT1
chr11
65422774
65445540
+
NUTM2A-AS1
chr10
87201647
87342612
-
AC021078.1
chr5
149494314
149504670
-
SNHG25
chr17
64145970
64146476
+
AC079781.5
chr7
97851688
97972985
-
LINC02035
chr3
122886941
122892416
+
LINC00662
chr19
27681072
27794005
-
AL359924.1
chr1
237862175
237928321
+
FGD5-AS1
chr3
14920347
14948424
-
AC009022.1
chr16
69976297
70065948
-
AC114980.1
chr5
93860669
93863825
-
MZF1-AS1
chr19
58559129
58574797
+
AL031282.2
chr1
1702736
1737688
-
AC003092.1
chr7
94022833
94066661
+
AC020978.7
chr16
68224713
68227734
+
MIR497HG
chr17
7015818
7019659
-
AP000317.2
chr21
34073592
34360033
+
AC002470.2
chr22
20979462
20998121
+
HCG18
chr6
30286690
30327382
-
MIR503HG
chrX
134543119
134546642
-
SNHG12
chr1
28578538
28583132
-
NUTM2B-AS1
chr10
79661394
79826594
-
LINC00649
chr21
33915534
33977691
+
AC021092.1
chr19
44103007
44113183
-
SNHG16
chr17
76557764
76565348
+
SNHG1
chr11
62851984
62855953
-
STAG3L5P-PVRIG2P-PILRB
chr7
100336104
100367831
+
MCM3AP-AS1
chr21
46229196
46259390
+
MIR29B2CHG
chr1
207801518
207879115
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.